Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

Kalampokis, 2013, IL-10-producing regulatory B cells (B10 cells) in autoimmune disease., Arthritis Res Ther, 15, S1, 10.1186/ar3907 Mizoguchi, 2006, A case for regulatory B cells., J Immunol, 176, 705, 10.4049/jimmunol.176.2.705 Mizoguchi, 2002, Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation., Immunity, 16, 219, 10.1016/S1074-7613(02)00274-1 Fillatreau, 2002, B cells regulate autoimmunity by provision of IL-10., Nat Immunol, 3, 944, 10.1038/ni833 Mauri, 2003, Prevention of arthritis by interleukin 10-producing B cells., J Exp Med, 197, 489, 10.1084/jem.20021293 Wei, 2005, Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets., Proc Natl Acad Sci USA, 102, 2010, 10.1073/pnas.0409449102 Mauri, 2012, Immune regulatory function of B cells., Annu Rev Immunol, 30, 221, 10.1146/annurev-immunol-020711-074934 Mauri, 2010, Regulatory B cells in autoimmunity: developments and controversies., Nat Rev Rheumatol, 6, 636, 10.1038/nrrheum.2010.140 Matsushita, 2011, Identifying regulatory B cells (B10 cells) that produce IL-10 in mice., Methods Mol Biol, 677, 99, 10.1007/978-1-60761-869-0_7 Blair, 2010, CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients., Immunity, 32, 129, 10.1016/j.immuni.2009.11.009 Iwata, 2011, Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells., Blood, 117, 530, 10.1182/blood-2010-07-294249 Li, 2012, Defective regulatory B-cell compartment in patients with immune thrombocytopenia., Blood, 120, 3318, 10.1182/blood-2012-05-432575 Saussine, 2012, Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels., PLoS ONE, 7, e43588, 10.1371/journal.pone.0043588 Correale, 2008, Helminth infections associated with multiple sclerosis induce regulatory B cells., Ann Neurol, 64, 187, 10.1002/ana.21438 Rezvani, 2006, High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT., Blood, 108, 1291, 10.1182/blood-2006-02-003996 Mielke, 2007, Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease., Blood, 110, 1689, 10.1182/blood-2007-03-079160 Zorn, 2005, Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease., Blood, 106, 2903, 10.1182/blood-2005-03-1257 Kapur, 2008, B-cell involvement in chronic graft-versus-host disease., Haematologica, 93, 1702, 10.3324/haematol.13311 Allen, 2012, B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways., Blood, 120, 2529, 10.1182/blood-2012-06-438911 Sanz, 2008, Phenotypic and functional heterogeneity of human memory B cells., Semin Immunol, 20, 67, 10.1016/j.smim.2007.12.006 van Kooten, 2000, CD40-CD40 ligand., J Leukoc Biol, 67, 2, 10.1002/jlb.67.1.2 Iwata, 2011, Characterization of a rare IL-10-competent B-cell subset in man that parallels mouse regulatory B10 cells., Blood, 117, 530, 10.1182/blood-2010-07-294249 Filipovich, 2005, National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report., Biol Blood Marrow Transplant, 11, 945, 10.1016/j.bbmt.2005.09.004 Atkinson, 2003, Clinical Bone Marrow and Blood Stem Cell Transplantation Corre, 2010, Long-term immune deficiency after allogeneic stem cell transplantation: B-cell deficiency is associated with late infections., Haematologica, 95, 1025, 10.3324/haematol.2009.018853 Sarantopoulos, 2009, Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease., Blood, 113, 3865, 10.1182/blood-2008-09-177840 Hilgendorf, 2012, The lack of memory B cells including T cell independent IgM+ IgD+ memory B cells in chronic graft-versus host disease is associated with susceptibility to infection., Transpl Int, 25, 87, 10.1111/j.1432-2277.2011.01388.x Yamashita, 2004, Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells., Blood, 103, 3986, 10.1182/blood-2003-09-3286 Shulman, 1980, Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients., Am J Med, 69, 204, 10.1016/0002-9343(80)90380-0 Bouaziz, 2010, IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro., Eur J Immunol, 40, 2686, 10.1002/eji.201040673 Yanaba, 2008, A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses., Immunity, 28, 639, 10.1016/j.immuni.2008.03.017 Yanaba, 2009, The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals., J Immunol, 182, 7459, 10.4049/jimmunol.0900270 Gray, 2007, Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells., Proc Natl Acad Sci USA, 104, 14080, 10.1073/pnas.0700326104 Evans, 2007, Novel suppressive function of transitional 2 B cells in experimental arthritis., J Immunol, 178, 7868, 10.4049/jimmunol.178.12.7868 Blair, 2009, Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice., J Immunol, 182, 3492, 10.4049/jimmunol.0803052 Asadullah, 2003, Interleukin-10 therapy—review of a new approach., Pharmacol Rev, 55, 241, 10.1124/pr.55.2.4 Goerner, 2002, Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias., Biol Blood Marrow Transplant, 8, 47, 10.1053/bbmt.2002.v8.pm11858190 Le Huu, 2013, Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease., Blood, 121, 3274, 10.1182/blood-2012-11-465658 Weber, 2014, Donor and host B cell-derived IL-10 contributes to suppression of graft-versus-host disease., Eur J Immunol, 44, 1857, 10.1002/eji.201344081 Barak, 1995, Cytokine dysregulation in chronic graft versus host disease., Leuk Lymphoma, 17, 169, 10.3109/10428199509051718 Liem, 1999, Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease., Transplantation, 67, 59, 10.1097/00007890-199901150-00009 Körholz, 1997, Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation., Bone Marrow Transplant, 19, 691, 10.1038/sj.bmt.1700718 Wykes, 2003, Why do B cells produce CD40 ligand?, Immunol Cell Biol, 81, 328, 10.1046/j.1440-1711.2003.01171.x Sarantopoulos, 2011, Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease., Blood, 117, 2275, 10.1182/blood-2010-10-307819 Kuzmina, 2011, Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia., Blood, 117, 2265, 10.1182/blood-2010-07-295766 Cutler, 2006, Rituximab for steroid-refractory chronic graft-versus-host disease., Blood, 108, 756, 10.1182/blood-2006-01-0233